367 related articles for article (PubMed ID: 17472698)
1. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.
Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents.
Mizoguchi H; Yamada K; Nabeshima T
J Pharmacol Sci; 2008 Jan; 106(1):9-14. PubMed ID: 18198472
[TBL] [Abstract][Full Text] [Related]
3. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice.
Mizoguchi H; Yamada K; Niwa M; Mouri A; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
J Neurochem; 2007 Mar; 100(6):1579-88. PubMed ID: 17348864
[TBL] [Abstract][Full Text] [Related]
4. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
5. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
[TBL] [Abstract][Full Text] [Related]
6. Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization.
Cen X; Nitta A; Ibi D; Zhao Y; Niwa M; Taguchi K; Hamada M; Ito Y; Ito Y; Wang L; Nabeshima T
Mol Psychiatry; 2008 Apr; 13(4):349, 451-63. PubMed ID: 18195717
[TBL] [Abstract][Full Text] [Related]
7. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
[TBL] [Abstract][Full Text] [Related]
8. Role of serine racemase in behavioral sensitization in mice after repeated administration of methamphetamine.
Horio M; Kohno M; Fujita Y; Ishima T; Inoue R; Mori H; Hashimoto K
PLoS One; 2012; 7(4):e35494. PubMed ID: 22530033
[TBL] [Abstract][Full Text] [Related]
9. The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect.
Huang M; Kong L; Yang L; Li X; Zhou X; Li Y; Bai J
Behav Brain Res; 2018 Jan; 337():280-286. PubMed ID: 28782589
[TBL] [Abstract][Full Text] [Related]
10. Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats.
Narita M; Akai H; Kita T; Nagumo Y; Narita M; Sunagawa N; Hara C; Hasebe K; Nagase H; Suzuki T
Neuroscience; 2005; 132(3):553-60. PubMed ID: 15837117
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism.
Uno K; Miyazaki T; Sodeyama K; Miyamoto Y; Nitta A
PLoS One; 2017; 12(3):e0174196. PubMed ID: 28319198
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
Maeda T; Kiguchi N; Fukazawa Y; Yamamoto A; Ozaki M; Kishioka S
Neuropsychopharmacology; 2007 May; 32(5):1133-40. PubMed ID: 17019405
[TBL] [Abstract][Full Text] [Related]
13. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
14. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice.
Miyamoto Y; Ishikawa Y; Iegaki N; Sumi K; Fu K; Sato K; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Uno K; Nitta A
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1283-94. PubMed ID: 24559655
[TBL] [Abstract][Full Text] [Related]
16. An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization.
Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Shen L; Noda Y; Furukawa S; Nabeshima T
Biol Psychiatry; 2007 Apr; 61(7):890-901. PubMed ID: 17046726
[TBL] [Abstract][Full Text] [Related]
17. Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence.
Toriumi K; Kondo M; Nagai T; Hashimoto R; Ohi K; Song Z; Tanaka J; Mouri A; Koseki T; Yamamori H; Furukawa-Hibi Y; Mamiya T; Fukushima T; Takeda M; Nitta A; Yamada K; Nabeshima T
Int J Neuropsychopharmacol; 2014 Mar; 17(3):443-53. PubMed ID: 24246274
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D
Tu G; Ying L; Ye L; Zhao J; Liu N; Li J; Liu Y; Zhu M; Wu Y; Xiao B; Guo H; Guo F; Wang H; Zhang L; Zhang L
Biol Psychiatry; 2019 Dec; 86(11):820-835. PubMed ID: 31060803
[TBL] [Abstract][Full Text] [Related]
19. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
[TBL] [Abstract][Full Text] [Related]
20. Depletion of D3 dopamine receptor affects methamphetamine-induced expression patterns of Pde4b and Atf3.
Chen Y; Yang C; Zhu L; Li J; Guan F; Chen T
Neurosci Lett; 2018 Feb; 665():54-60. PubMed ID: 29175029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
